查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1963924

醫療保健第三方物流市場－全球產業規模、佔有率、趨勢、機會與預測：按產業、服務類型、供應鏈、地區和競爭對手分類，2021-2031年

Healthcare Third party Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Industry, By Service Type, By Supply Chain, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療保健第三方物流市場預計將從 2025 年的 2.6634 億美元成長到 2031 年的 4.0693 億美元，複合年成長率達到 7.32%。

該市場指的是將運輸、倉儲和庫存管理等供應鏈管理職能策略性外包給專業的外部供應商，其主要促進因素是醫藥貿易的全球化、對溫度生物製藥分銷日益複雜化，以及製造商需要透過外部專業知識來最佳化營運成本。

市場概覽
預測期 2027-2031
市場規模：2025年 2.6634億美元
市場規模：2031年 4.0693億美元
複合年成長率：2026-2031年 7.32%
成長最快的細分市場 製藥
最大的市場 北美洲

根據歐洲製藥工業協會聯合會（EFPIA）的估計值，到2024年，北美將佔全球藥品銷售額的54.8%。如此龐大的規模表明，需要建立強大的物流網路來處理跨區域的醫療產品分銷。然而，由於監管環境複雜且分散，該市場面臨巨大的挑戰。不同司法管轄區的合規標準各不相同，提出了嚴格的要求，這不僅增加了物流供應商的營運複雜性，也增加了其責任風險。

市場促進因素

生物製藥、疫苗和細胞療法的快速成長推動了對溫控低溫運輸物流需求的激增，這些產品需要嚴格的熱穩定性以防止變質，從而從根本上改變了全球醫療保健第三方物流市場。正如馬士基在2024年4月發布的報告預測，當年全球生物製藥低溫運輸物流支出預計將達到213億美元，而蓬勃發展的國際貿易網路也支撐了這一趨勢。國際航空運輸協會（IATA）指出，2024年全球航空貨運需求增加了11.3%，凸顯了對醫療保健供應鏈至關重要的國際運輸量的顯著成長。

第二個主要促進因素是外包非核心物流業務的趨勢日益成長。這使得製藥公司能夠專注於研發，同時透過將複雜的供應鏈營運委託給外部專家，降低成本並避免維護內部基礎設施。物流供應商正積極擴大產能以滿足此需求。例如，DHL供應鏈於2024年2月宣布投資2億美元，用於擴展其在美國生命科學和醫療保健領域的基礎設施，旨在滿足該領域日益成長的需求，特別是對專業倉儲和配送解決方案的需求。

市場挑戰

複雜且分散的監管環境對全球醫療保健第三方物流市場的擴張構成重大障礙。供應商必須應對錯綜複雜的合規標準，包括良好分銷規範 (GDP) 和序列化要求，而這些要求因地區而異。這種不協調迫使企業維持專門的品質保證團隊和冗餘的合規系統，導致營運成本增加、責任風險加大，以及將關鍵資源從基礎設施建設和市場擴張中轉移出去。

這些嚴格要求帶來的經濟影響體現在產業盈利的下降，從而限制了可用於成長的資金。 2024年，醫療保健分銷商聯盟（HDA）報告稱，藥品經銷商的淨利率降至僅0.2%。獲利能力的下降是由於遵守嚴格的營運和合規標準所帶來的高成本，這嚴重限制了物流供應商投資必要技術升級或進入新的複雜市場的財務能力。

市場趨勢

將人工智慧驅動的預測分析應用於需求預測，正在改變市場格局，使供應商能夠考慮天氣和地緣政治事件等風險，預測中斷情況，並即時最佳化路線。這種向主動式供應鏈管理的轉變對於高價值藥品至關重要。正如《供應鏈管理執行官》2025年11月刊所指出的，53%的藥品價值鏈領導者目前正在投資人工智慧和機器學習，尤其用於產生預測性風險警報和增強營運韌性。

同時，在製藥企業努力透過使用電動車和永續航空燃料（SAF）來減少範圍3排放的背景下，採用永續和環保的物流措施正成為供應商選擇的關鍵因素。這種轉型是滿足客戶永續性要求和全球法規的策略性需求。例如，根據《碳權》（Carbon Credits）2025年12月的一篇報導，DHL Express已簽署一份具有約束力的契約，採購5000萬升SAF以支持其航空貨運業務，直接滿足了行業對低碳運輸解決方案日益成長的需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球醫療保健第三方物流市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依行業（生物製藥、醫療設備、藥品）
    • 服務類型（運輸、倉儲、其他）
    • 按類型分類的供應鏈（低溫運輸、非低溫運輸）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美醫療保健第三方物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫療保健第三方物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區醫療保健第三方物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲醫療保健第三方物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美醫療保健第三方物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球醫療保健第三方物流市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Cardinal Health
  • DHL Group
  • SF Express
  • Kinesis Medical BV
  • United Parcel Service of America, Inc.
  • Barrett Distribution
  • AmerisourceBergen Corporation
  • KUEHNE+NAGEL
  • Kerry Logistics Network Ltd.
  • Freight Logistics Solutions

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20736

The Global Healthcare Third-party Logistics Market is projected to expand from USD 266.34 Million in 2025 to USD 406.93 Million by 2031, achieving a compound annual growth rate of 7.32%. Defined as the strategic outsourcing of supply chain management functions-such as transportation, warehousing, and inventory control-to specialized external providers, the market is primarily driven by the globalization of pharmaceutical trade, the growing complexity of distributing temperature-sensitive biologics, and the necessity for manufacturers to optimize operational costs through external expertise.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 266.34 Million
Market Size 2031USD 406.93 Million
CAGR 2026-20317.32%
Fastest Growing SegmentPharmaceutical
Largest MarketNorth America

According to the European Federation of Pharmaceutical Industries and Associations, North America represented 54.8% of estimated global pharmaceutical sales in 2024, a volume that underscores the critical need for robust logistical networks to handle medical product flows across diverse regions. However, the market faces significant challenges due to an intricate and fragmented regulatory landscape; varying compliance standards across different jurisdictions enforce rigorous requirements that increase both operational complexity and liability risks for logistics providers.

Market Driver

A surging demand for temperature-controlled cold chain logistics is fundamentally reshaping the Global Healthcare Third-party Logistics Market, necessitated by the rapid growth of biologics, vaccines, and cell therapies that require strict thermal stability to avoid spoilage. As reported by Maersk in April 2024, global expenditure on biopharma cold chain logistics was projected to reach $21.3 billion that year, a trend supported by the vitality of global trade networks; the International Air Transport Association noted that global air cargo demand rose by 11.3% in 2024, highlighting the substantial volume of international shipments crucial for healthcare supply chains.

A second primary driver is the increasing trend of outsourcing non-core logistics operations, which allows pharmaceutical companies to focus on research and development while delegating complex supply chain tasks to external experts to save costs and avoid maintaining in-house infrastructure. Logistics providers are aggressively scaling their capabilities to meet this demand; for instance, DHL Supply Chain announced a $200 million investment in February 2024 to expand its life sciences and healthcare infrastructure in the United States, specifically aiming to accommodate the sector's rising need for specialized warehousing and distribution solutions.

Market Challenge

The intricate and fragmented regulatory landscape poses a formidable barrier to the expansion of the Global Healthcare Third-party Logistics Market, as providers must navigate a complex web of compliance standards like Good Distribution Practices (GDP) and serialization mandates that differ significantly by jurisdiction. This lack of harmonization forces companies to maintain specialized quality assurance teams and redundant compliance systems, which drives up operational overhead, increases liability risks, and diverts critical resources away from infrastructure development and market expansion.

The economic consequences of these stringent requirements are reflected in the sector's diminishing profitability, which restricts the capital available for growth. In 2024, the Healthcare Distribution Alliance reported that net profit margins for pharmaceutical distributors dropped to just 0.2 percent; these constricted margins, resulting from the high costs of adhering to rigorous operational and compliance standards, severely limit the financial capacity of logistics providers to invest in necessary technology upgrades or enter new, complex markets.

Market Trends

The integration of AI-driven predictive analytics for demand forecasting is transforming the market by enabling providers to anticipate disruptions and optimize routes in real-time, accounting for risks such as weather or geopolitical events. This shift toward proactive supply chain management is essential for high-value pharmaceuticals, as highlighted by a November 2025 report in Supply & Demand Chain Executive, which noted that 53% of pharmaceutical supply chain leaders are currently evaluating AI and machine learning specifically to generate predictive risk alerts and enhance operational resilience.

Simultaneously, the implementation of sustainable and green logistics initiatives is becoming a decisive factor in vendor selection, driven by pharmaceutical manufacturers' commitments to reduce Scope 3 emissions through the use of electric vehicles and sustainable aviation fuels (SAF). This transition is a strategic imperative to meet client sustainability mandates and global regulations; for example, a December 2025 Carbon Credits article reported that DHL Express secured a binding contract for 50 million liters of SAF to support its air cargo operations, directly addressing the sector's growing demand for low-carbon transport solutions.

Key Market Players

  • Cardinal Health
  • DHL Group
  • SF Express
  • Kinesis Medical B.V.
  • United Parcel Service of America, Inc.
  • Barrett Distribution
  • AmerisourceBergen Corporation
  • KUEHNE + NAGEL
  • Kerry Logistics Network Ltd.
  • Freight Logistics Solutions

Report Scope

In this report, the Global Healthcare Third party Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Healthcare Third party Logistics Market, By Industry

  • Biopharmaceutical
  • Medical Device
  • Pharmaceutical

Healthcare Third party Logistics Market, By Service Type

  • Transportation
  • Warehousing and Storage
  • Others

Healthcare Third party Logistics Market, By Supply Chain

  • Cold Chain
  • Non-Cold Chain

Healthcare Third party Logistics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Third party Logistics Market.

Available Customizations:

Global Healthcare Third party Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Healthcare Third party Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Industry (Biopharmaceutical, Medical Device, Pharmaceutical)
    • 5.2.2. By Service Type (Transportation, Warehousing and Storage, Others)
    • 5.2.3. By Supply Chain (Cold Chain, Non-Cold Chain)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Healthcare Third party Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Industry
    • 6.2.2. By Service Type
    • 6.2.3. By Supply Chain
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Healthcare Third party Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Industry
        • 6.3.1.2.2. By Service Type
        • 6.3.1.2.3. By Supply Chain
    • 6.3.2. Canada Healthcare Third party Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Industry
        • 6.3.2.2.2. By Service Type
        • 6.3.2.2.3. By Supply Chain
    • 6.3.3. Mexico Healthcare Third party Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Industry
        • 6.3.3.2.2. By Service Type
        • 6.3.3.2.3. By Supply Chain

7. Europe Healthcare Third party Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Industry
    • 7.2.2. By Service Type
    • 7.2.3. By Supply Chain
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Healthcare Third party Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Industry
        • 7.3.1.2.2. By Service Type
        • 7.3.1.2.3. By Supply Chain
    • 7.3.2. France Healthcare Third party Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Industry
        • 7.3.2.2.2. By Service Type
        • 7.3.2.2.3. By Supply Chain
    • 7.3.3. United Kingdom Healthcare Third party Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Industry
        • 7.3.3.2.2. By Service Type
        • 7.3.3.2.3. By Supply Chain
    • 7.3.4. Italy Healthcare Third party Logistics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Industry
        • 7.3.4.2.2. By Service Type
        • 7.3.4.2.3. By Supply Chain
    • 7.3.5. Spain Healthcare Third party Logistics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Industry
        • 7.3.5.2.2. By Service Type
        • 7.3.5.2.3. By Supply Chain

8. Asia Pacific Healthcare Third party Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Industry
    • 8.2.2. By Service Type
    • 8.2.3. By Supply Chain
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Healthcare Third party Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Industry
        • 8.3.1.2.2. By Service Type
        • 8.3.1.2.3. By Supply Chain
    • 8.3.2. India Healthcare Third party Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Industry
        • 8.3.2.2.2. By Service Type
        • 8.3.2.2.3. By Supply Chain
    • 8.3.3. Japan Healthcare Third party Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Industry
        • 8.3.3.2.2. By Service Type
        • 8.3.3.2.3. By Supply Chain
    • 8.3.4. South Korea Healthcare Third party Logistics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Industry
        • 8.3.4.2.2. By Service Type
        • 8.3.4.2.3. By Supply Chain
    • 8.3.5. Australia Healthcare Third party Logistics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Industry
        • 8.3.5.2.2. By Service Type
        • 8.3.5.2.3. By Supply Chain

9. Middle East & Africa Healthcare Third party Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Industry
    • 9.2.2. By Service Type
    • 9.2.3. By Supply Chain
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Healthcare Third party Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Industry
        • 9.3.1.2.2. By Service Type
        • 9.3.1.2.3. By Supply Chain
    • 9.3.2. UAE Healthcare Third party Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Industry
        • 9.3.2.2.2. By Service Type
        • 9.3.2.2.3. By Supply Chain
    • 9.3.3. South Africa Healthcare Third party Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Industry
        • 9.3.3.2.2. By Service Type
        • 9.3.3.2.3. By Supply Chain

10. South America Healthcare Third party Logistics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Industry
    • 10.2.2. By Service Type
    • 10.2.3. By Supply Chain
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Healthcare Third party Logistics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Industry
        • 10.3.1.2.2. By Service Type
        • 10.3.1.2.3. By Supply Chain
    • 10.3.2. Colombia Healthcare Third party Logistics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Industry
        • 10.3.2.2.2. By Service Type
        • 10.3.2.2.3. By Supply Chain
    • 10.3.3. Argentina Healthcare Third party Logistics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Industry
        • 10.3.3.2.2. By Service Type
        • 10.3.3.2.3. By Supply Chain

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Healthcare Third party Logistics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cardinal Health
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DHL Group
  • 15.3. SF Express
  • 15.4. Kinesis Medical B.V.
  • 15.5. United Parcel Service of America, Inc.
  • 15.6. Barrett Distribution
  • 15.7. AmerisourceBergen Corporation
  • 15.8. KUEHNE + NAGEL
  • 15.9. Kerry Logistics Network Ltd.
  • 15.10. Freight Logistics Solutions

16. Strategic Recommendations

17. About Us & Disclaimer